Search Results for: covid-19
Articles
3M Drug Delivery Systems Launches as Independent Company, Kindeva Drug Delivery May 5, 2020
Kindeva Drug Delivery, formerly 3M Drug Delivery Systems, recently announced its launch as an independent company following the acquisition by Altaris Capital Partners in a transaction valued at….
Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial April 9, 2020
Precision BioSciences, Inc. recently announced the initiation of patient dosing in a Phase 1/2a clinical trial of its second off-the-shelf (allogeneic) chimeric….
Antiviral Drugs Market to Foresee Tremendous Gains Over 2020-2026 April 9, 2020
The global antiviral drugs market was valued at $56 billion in 2019 and is expected to accrue phenomenal gains over...Aravive Announces AVB-500 Improves Anti-Tumor Effects When Combined With Anti-Angiogenic Bevacizumab or PARP Inhibitor Olaparib April 1, 2020
Aravive, Inc. recently announced that AVB-500 improves anti-tumor effects when combined with the anti-angiogenic bevacizumab or the PARP inhibitor olaparib...Carterra Selected by La Jolla Institute of Immunology to Provide Antibody Screening & Characterization for the Coronavirus Immunotherapy Consortium (CoVIC) April 1, 2020
Carterra Inc. and La Jolla Institute for Immunology (LJI), announced today that they will use Carterra’s proprietary LSA platform to...Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate From Premas Biotech March 25, 2020
Akers Biosciences, Inc. recently announced it has acquired a licensing agreement with Premas Biotech, under which Akers will in-license a novel coronavirus vaccine candidate under development by…..
WPD Pharmaceuticals Partners With CNS Pharmaceuticals on Drug Development for Coronavirus & Other Antiviral Indications March 25, 2020
WPD Pharmaceuticals Inc. recently announced it has entered into a development agreement with CNS Pharmaceuticals, Inc. for the development of……
Novavax’s NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial March 25, 2020
Novavax, Inc. recently announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu, its recombinant quadrivalent seasonal...Rafael Pharmaceuticals Enrolls More Than 75% of Patients Needed for Pivotal Phase 3 Trial March 25, 2020
Rafael Pharmaceuticals, Inc. recently announced it has enrolled more than 75% of the 500 patients needed for its pivotal Phase...Enlivex Announces Positive Final Safety & Efficacy Data From Clinical Trial March 19, 2020
Enlivex Therapeutics Ltd. recently announced positive final safety and efficacy data from the company’s completed Phase 1b clinical trial in...Emergent BioSolutions Initiates Development of Plasma-Derived Product Candidates for the Treatment & Prevention of Coronavirus Disease March 12, 2020
Emergent BioSolutions Inc. recently announced it has initiated development of two product candidates for the treatment and prevention of coronavirus...ADMA Biologics Highlights Expanded Intellectual Property Portfolio March 5, 2020
ADMA Biologics recently announced that it has received another Notice of Allowance from the US Patent and Trademark Office (USPTO) for a patent application related to its…..
Cocrystal Pharma's Structure-Based Technology Demonstrated Broad Utility February 14, 2020
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics using its proprietary structure-based drug discovery...
